List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 429 studies with search of: psoriasis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: Etanercept
2 Recruiting A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Placebo;   Drug: AEB071;   Other: AEB071
3 Recruiting Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:
4 Completed Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
5 Active, not recruiting Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Conditions: Psoriasis;   Plaque-Type Psoriasis
Interventions: Drug: Apremilast 10mg BID;   Drug: Apremilast 20mg BID;   Drug: Placebo
6 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:
7 Active, not recruiting CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
Condition: Psoriasis
Intervention: Drug: Cyclosporine A versus mycophenolate mofetil for psoriasis
8 Not yet recruiting Prevalence of Sleep Disturbances in Psoriasis
Condition: Psoriasis
Intervention:
9 Completed
Has Results 		A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
Condition: Psoriasis
Intervention: Biological: Humira (adalimumab)
10 Completed Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
Condition: Psoriasis
Interventions: Device: NB-UVB;   Drug: Etanerept;   Drug: Etanercept
11 Completed Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
Condition: Psoriasis
Intervention: Drug: Calcipotriene/betamethasone gel and ointment
12 Recruiting Peds Metabolic Syndrome in Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome
Intervention:
13 Recruiting Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome;   Hyperlipidemia;   Obesity;   Hypertension
Intervention: Drug: Etanercept (TNF-alpha antagonist)
14 Completed Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Condition: Psoriasis
Intervention: Drug: Etanercept
15 Active, not recruiting A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
Condition: Psoriasis
Intervention:
16 Completed Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
Condition: Palmoplantar Psoriasis
Interventions: Drug: Placebo;   Drug: Infliximab
17 Completed Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
Condition: Psoriasis
Intervention: Drug: CC10004
18 Completed A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
Condition: Psoriasis
Intervention: Drug: Efalizumab - anti CD11a recombinant human monoclonal antibody
19 Recruiting A Study for Adults With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: LY2525623 Intravenous;   Drug: LY2525623 Subcutaneous;   Drug: Placebo Intravenous;   Drug: Placebo subcutaneous
20 Suspended Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
Condition: Psoriasis
Interventions: Procedure: Psoriasis Area and Severity Index (PASI);   Procedure: Static Physicians Global Assessment (sPGA);   Procedure: Dermatology Life Quality Index (DLQI)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services